COVID-19, the BC-CfE Response

Presenters:
Dr. Julio Montaner
Executive Director & Physician-in-Chief
BC-CfE

Dr. Peter Phillips
Clinical Professor
Division of Infectious Diseases, University of British Columbia

Dr. Zabrina Brumme
Laboratory Director, BC Centre for Excellence in HIV/AIDS
Professor, Faculty of Health Sciences, Simon Fraser University
Scholar, Michael Smith Foundation for Health Research

Junine Toy, Pharm D
Senior Manager, BC Centre for Excellence in HIV/AIDS Drug Treatment Program
Clinical Pharmacy Specialist, St. Paul’s Hospital

Share this video:
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below